Biglycan, a small leucine-rich proteoglycan, is a ubiquitous ECM component; however, its biological role has not been elucidated in detail. Here we show that biglycan acts in macrophages as an endogenous ligand of TLR4 and TLR2, which mediate innate immunity, leading to rapid activation of p38, ERK, and NF-κB and thereby stimulating the expression of TNF-α and macrophage inflammatory protein-2 (MIP-2). In agreement, the stimulatory effects of biglycan are significantly reduced in TLR4-mutant (TLR4-M), TLR2 -/-, and myeloid differentiation factor 88 -/-(MyD88 -/-) macrophages and completely abolished in TLR2 -/-/TLR4-M macrophages. Biglycan-null mice have a considerable survival benefit in LPS-or zymosan-induced sepsis due to lower levels of circulating TNF-α and reduced infiltration of mononuclear cells in the lung, which cause less end-organ damage. Importantly, when stimulated by LPS-induced proinflammatory factors, macrophages themselves are able to synthesize biglycan. Thus, biglycan, upon release from the ECM or from macrophages, can boost inflammation by signaling through TLR4 and TLR2, thereby enhancing the synthesis of TNF-α and MIP-2. Our results provide evidence for what is, to our knowledge, a novel role of the matrix component biglycan as a signaling molecule and a crucial proinflammatory factor. These findings are potentially relevant for the development of new strategies in the treatment of sepsis.
Introduction
Biglycan (BGN), a member of the family of small leucine-rich proteoglycans (SLRPs), consists of a core protein and a chondroitin/ dermatan sulfate chain(s) (1). Although it is abundant in many tissues, its biological functions remain poorly understood. BGN is considered to have an organizing role in the assembly of the ECM. Targeted disruption of the BGN gene results in abnormal collagen fibril morphology (2) and an osteoporosis-like phenotype (3) . BGN is also directly involved in cell signaling. By regulating the interaction of bone morphogenic protein-4 with its inhibitor chordin, it modulates signaling of this morphogen (4) . Furthermore, BGN may affect signal transduction during cell growth and differentiation via induction of the cyclin-dependent kinase inhibitor p27 KIP1 (5) . BGN-induced activation of RhoA and Rac1 signaling increases migration of lung fibroblasts (6) . Moreover, adenovirus-mediated gene transfer of BGN induced a fibroblastic response in the lung, indicating a role of BGN in fibrogenesis (7) .
There is growing evidence that ECM molecules may convey proinflammatory signals (8) (9) (10) (11) (12) (13) . Previously, we reported increased expression of BGN in renal inflammation, associated with heavy infiltration of BGN-expressing macrophages (14) . More recent data indicated that BGN expression is regulated by nitric oxide in monocyte-like mesangial cells (15) . Based on its capacity to bind TGF-β (16) and TNF-α (17) , BGN may be involved in regulating cytokine activity. BGN seems to be required for growth and differentiation of monocytic-lineage cells (18) . Like other gene products involved in pathogen recognition (TLRs, resistance genes in plants, CD14, nucleotide-binding oligomerization domain proteins) (19, 20) , the BGN core protein contains leucine-rich repeats that facilitate protein-protein interactions (1). Recently, binding of BGN to the scavenger receptor class A (SR-A) and the endocytic mannose receptor (21, 22) , 2 pattern recognition receptors on macrophages (23) , has been reported. Therefore, we investigated whether BGN is part of the innate immune system and a potential innate antigen analogous to pathogen-associated molecular patterns (PAMPs).
TLRs are seminal immune receptors that are capable of sensing PAMPs of organisms ranging from protozoa to bacteria, fungi, and viruses (24, 25) . The inflammatory response of macrophages to LPS is mediated mainly by a receptor complex composed of TLR4, CD14, and myeloid differentiation protein-2 (MD-2) (24, (26) (27) (28) , which is critically important in innate immune recognition of Gram-negative pathogens. TLR2 participates in the recognition of Gram-positive bacteria, peptidoglycan, and yeast zymosan (24) . Although TLR4 and TLR2 are highly specific in their pathogen recognition and activation of signal transduction, they share a common signaling pathway (20, 24) involving an intracellular adapter protein called myeloid differentiation factor 88 (MyD88) (29) , rapid phosphorylation of ERK (30) and p38 (31) , and rapid downstream activation of NF-κB (32) , which lead to the expression of TNF-α and macrophage inflammatory protein-2 (MIP-2) (20) .
Here we demonstrate that biglycan-null (Bgn-null) mice have a considerable survival benefit in LPS- or zymosan-induced sepsis, due to lower levels of circulating TNF-α and reduced infiltration of mononuclear cells in the lungs. In macrophages, BGN induced signaling through TLR4 and TLR2, leading to rapid activation of p38, ERK, and NF-κB and finally to a pronounced expression of TNF-α and MIP-2. This study provides evidence that BGN is a secretory product of macrophages that can act as a "danger" motif analogous to PAMPs, exerting proinflammatory functions by signaling through TLR4 and TLR2.
Results

Improved survival of Bgn-deficient mice in LPS-induced sepsis. To inves-
tigate the influence of BGN on systemic inflammation, sepsis was induced in female Bgn +/+ , Bgn +/-, and Bgn -/-mice and in male Bgn +/0 and Bgn -/0 mice by i.p. injection of LPS. On average, 8-week-old Bgn +/0 mice died at 30 ± 8 hours after injection, while Bgn -/0 animals survived for 95 ± 19 hours (n = 6, P < 0.05) ( Figure 1A ). Ninety minutes after injection of LPS, plasma TNF-α levels were 6 times lower in Bgn -/0 mice than in WT animals, while Bgn -/0 and Bgn +/0 mice not treated with LPS had identical plasma levels of TNF-α ( Figure 1B) . Similarly, female Bgn +/+ mice died much earlier (20 ± 2 hours, n = 7) than Bgn -/-mice (127 ± 39 h, n = 5, P < 0.05), of which 2 animals even survived the treatment ( Figure 1C ). Again, improved survival was associated with lower plasma levels of TNF-α ( Figure  1D ). However, Bgn +/-mice had no survival benefit (23 ± 2 hours, n = 7, P > 0.05) ( Figure 1C) , and TNF-α plasma levels were not significantly different from those in Bgn +/+ mice ( Figure 1D ). Thus, a lack of BGN prolongs survival of septic animals, probably by tempering the inflammatory cytokine response to endotoxin.
Increased expression of BGN attracts infiltrating cells to the lung parenchyma in sepsis.
To test whether BGN expression increases during septic inflammation in the lung, a major target organ in sepsis, Bgn +/0 mice were injected with a lethal dose of LPS. BGN mRNA (1.7 ± 0.2 times control, n = 3, P < 0.05, 2 hours of sepsis) ( Figure   2A ) and protein (1.6 ± 0.3 times control, n = 4, P < 0.05, 8 hours of sepsis) ( Figure 2B ) were increased in septic lungs compared with lungs from healthy mice. Immunostaining ( Figure 2 , C and D) and in situ hybridization confirmed these results and revealed macrophages as a source of BGN protein ( Figure 2E ) and mRNA expression ( Figure 2F ) in septic lungs. We previously demonstrated an association of increased expression of BGN with enhanced infiltration of mononuclear cells (14) . Therefore, absence of BGN might reduce inflammatory cell infiltration in septic lungs. Indeed, we found significantly fewer infiltrating mononuclear cells in the lungs of septic Bgn -/0 ( Figure 2H ) compared with Bgn +/0 mice ( Figure 2G ), as quantified by H&E staining and by F4/80 immunostaining ( Table 1) . The improved outcome of sepsis in Bgn -/0 mice cannot be attributed to a compensatory overexpression of decorin or fibromodulin in these animals (33) , as immunostainings for SLRPs both in the lung and in the liver revealed no differences from those in WT mice (data not shown). Furthermore, type I collagen ( Figure 2 , I and J), fibronectin ( Figure 2K ), laminin (Figure 2L) , and type VI collagen (not shown), all known to augment the adhesiveness of leukocytes (34, 35) , were equally increased in septic lungs from Bgn +/0 and Bgn -/0 mice.
LPS-triggered IL-1β and IL-6 lead to BGN expression, and BGN induces TNF-α and MIP-2 in macrophages. Given that BGN was increased in
LPS-septic lungs and macrophages acted as a source of BGN, we investigated whether BGN is produced by macrophages only during infection, and if so, what stimuli would trigger its synthesis. As the BGN promoter region contains an IL-6-responsive element (36), we hypothesized that LPS-induced proinflammatory cytokines may trigger BGN expression. LPS stimulation (1 hour) resulted in an equal increase of IL-6 ( Figure 3A ) and IL-1β ( Figure 3B ) levels in culture media from both Bgn +/0 and Bgn -/0 thioglycollate-elicited peritoneal macrophages. Unstimulated macrophages did not express BGN mRNA ( Figure 3C ) or protein ( Figure 3D ). However, upon stimulation with IL-1β or IL-6, WT macrophages expressed BGN mRNA ( Figure 3C ) and secreted BGN protein ( Figure 3D ).
As the rise in circulating TNF-α was blunted in septic Bgn-deficient mice, we subsequently investigated whether BGN influences the expression of TNF-α and MIP-2. Incubation of peritoneal macrophages from Bgn +/0 and Bgn -/0 mice with BGN for 6 hours led to increased mRNA levels of TNF-α (Bgn +/0 plus BGN: 5.5 ± 0.6 times Bgn +/0 ; Bgn -/0 plus BGN: 3.3 ± 0.4 times Bgn -/0 ; n = 3, P < 0.05) and lates TNF-α and MIP-2 expression in macrophages were explored. Within 10 minutes of incubation, BGN enhanced phosphorylation of ERK (3.5 ± 0.6 times control without BGN, n = 3, P < 0.05) and p38 (2.4 ± 0.5 times control, n = 3, P < 0.05) in thioglycollate-stimulated Bgn +/0 macrophages, reaching a maximum after 30 minutes (p-ERK/ERK: 5.1 ± 0.4 times control without BGN; p-p38/p38: 3.5 ± 0.6 times control without BGN; each n = 3, P < 0.05) with a return to normal levels within 120 minutes (Figure 4A) . Preincubation of macrophages for 1 hour with U0126, a specific inhibitor of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2), completely abolished ERK phosphorylation ( Figure  4B ) after 30 minutes. Furthermore, both U0126 and SB203580, an inhibitor of p38 phosphorylation, caused a significant reduction of BGN-induced secretion of TNF-α and MIP-2 into the culture media from BGN-stimulated macrophages after 6 hours ( Figure 4 , C and D). Finally, enhanced activation of NF-κB after 30 minutes of incubation with BGN was shown by electrophoretic mobility shift assay (EMSA) ( Figure 4E ). Taken together, these results show that the BGN-dependent induction of TNF-α and MIP-2 in macrophages involves the ERK, p38, and NF-κB pathways. BGN signals through TLR4 and TLR2 in macrophages. The effect of BGN on HEK293 cells, which functionally expressed human TLR2, -3, -4, -5, -7, -8, or -9 and an alkaline phosphatase gene under control of the IL-12p40 promoter, was tested. When 10 µg/ml BGN was used, only activation of TLR2 and TLR4 was observed ( Figure 5A ). A dose-response analysis showed that 10 µg/ml BGN stimulates TLR4 ( Figure 5B ) and TLR2 ( Figure 5C ) to the same extent that 10 ng/ml FSL-1 stimulates TLR2 or 1 ng/ml LPS-K12 stimulates TLR4.
Preincubation of macrophages from Bgn +/0 and Bgn -/0 mice with blocking anti-TLR4 antibodies significantly reduced the increase in TNF-α (Bgn +/0 , 43% ± 13%; Bgn -/0 , 76% ± 14%; percentage of inhibition calculated for the respective sample stimulated with BGN without blocking antibodies, n = 3, P < 0.05) and MIP-2 levels (Bgn +/0 , 34% ± 6%; Bgn -/0 , 55% ± 23%; percentage of inhibition, n = 3, P < 0.05) in culture media upon BGN stimulation after 6 hours.
Furthermore, incubation of Bgn -/0 macrophages with intact human BGN in the presence of a cross-linker and subsequent immunoprecipitation with anti-BGN antiserum showed that BGN coimmunoprecipitates with both TLR4 ( Figure 5D ) and TLR2 ( Figure 5E ). Electrospray ionization tandem mass spectrometry (ESI/MS/MS) analysis of 2 bands migrating at 42-44 kDa and a band at 96 kDa of the immunoprecipitate after digestion with chondroitinase ABC and separation by 1D gel electrophoresis (Figure 5F ) identified human BGN with a probability-based score of 221 ( Figure 5G ) and a sequence coverage of 13% ( Figure 5H ) and mouse TLR4 with a probability-based score of 528 ( Figure 5I ) and a sequence coverage of 8% ( Figure 5J ). Individual ion scores greater than 46 indicate identity or extensive homology (P < 0.05). Other significant hits ( Figure 5 , G and I) represented mainly keratins and trypsin. Note that band 2 ( Figure 5F ) was at the limit of detection, which is probably why TLR2 was not detected by ESI/MS/MS.
By gel filtration we could demonstrate interaction of BGN with a high-molecular weight complex containing TLR4 and/or TLR2, MD-2, and CD14 as shown in Supplemental Figure 2 .
Effects of BGN on phosphorylation of ERK and p38 were tested after 30 minutes in macrophages from WT (C57BL/6) mice, TLR2 -/-mice, C3H/HeJ mice hyporesponsive to LPS because of a point mutation in the TLR4 gene (TLR4-M) (26, 37) , TLR2 -/-/ TLR4-M mice, and MyD88 -/-mice (shown for ERK in Figure 6A ). Deficiency in either TLR2 or MyD88 as well as mutation in TLR4 markedly diminished BGN-mediated phosphorylation of ERK, while functional lack of both TLRs completely abolished phosphorylation ( Figure 6B ). These data provide evidence for differential signaling between BGN (4 µg/ml) and LPS (2 ng/ml), since LPS-mediated signaling was completely abolished in TLR4-M macrophages whereas BGN was still able to increase phosphorylation of ERK via TLR2 ( Figure 6, A and B) . Another difference was observed in MyD88 -/-macrophages, where BGN-mediated phosphorylation of ERK was strongly reduced ( Figure 6 , A and B), while LPS could still stimulate ERK via a MyD88-independent pathway ( Figure 6A ; WT plus LPS: 5.4 ± 0.8 times control without LPS; MyD88 -/-plus LPS: 3.8 ± 0.5 times control without LPS; each n = 3, P < 0.05). In agreement with this signaling pattern, BGN-induced increases in the levels of secreted TNF-α and MIP-2 were slightly reduced in TLR2 -/-, markedly decreased in TLR4-M and MyD88 -/-, and completely abrogated in TLR2 -/-/ TLR4-M macrophages ( Figure 6, C and D) . Finally, BGN-mediated activation of NF-κB was detected by EMSA in HEK293 cells transfected with human TLR4/MD-2/CD14 ( Figure 6E ). These data suggest that BGN is signaling in macrophages mainly through TLR4 in a MyD88-dependent manner, causing activation of NF-κB and MAPKs. Besides TLR4, TLR2 is also involved in BGNmediated signaling in macrophages.
To ensure that activation of macrophages by BGN was not attributable to contamination of the BGN preparation, we carefully ruled out the presence of LPS, other proinflammatory factors, and other TLR4 and TLR2 ligands (Supplemental Figure 3) .
Since in TLR2 -/-/TLR4-M macrophages an inflammatory response to BGN was completely abolished, the role of alternative receptors is very unlikely. However, as interactions of BGN with the SR-A type I (SR-AI) and the endocytic mannose receptor have been reported (21, 22) , we excluded a role of these receptors in BGN signaling (Supplemental Figure 4) .
Prolonged survival of Bgn-deficient mice in zymosan-induced sepsis but not in T cell-mediated lethal shock triggered by the superantigen staphylococcal enterotoxin B. To test whether TLR2-mediated activation of macrophages is relevant in vivo, zymosan-induced sepsis (38) was evaluated in Bgn -/0 and Bgn +/0 mice. Bgn -/0 mice revealed improved survival ( Figure 7A ), lower plasma levels of TNF-α ( Figure 7B) , and a reduced number of H&E- and F4/80-positive infiltrating cells in septic lungs (Table 1) . Finally, we induced a lethal shock syndrome triggered by staphylococcal enterotoxin B (SEB) in Bgn -/0 and Bgn +/0 mice sensitized by d-galactosamine hydrochloride. The basic differences between this model and LPS- or zymosaninduced sepsis are that SEB triggers activation of T lymphocytes, not macrophages, and that this model does not involve TLRs (39) . In this model, survival (Figure 7C ), plasma levels of TNF-α ( Figure   7D ), and the number of infiltrating mononuclear cells in the lungs (Bgn +/0 , 3.6 ± 0.5; Bgn -/0 , 3.9 ± 0.9; Bgn +/0 plus SEB, 4.8 ± 1.5; Bgn -/0 plus SEB, 3.8 ± 0.5; H&E, n = 4, P > 0.05) did not differ between Bgn -/0 and Bgn +/0 mice. Thus, these data provide further evidence for a role of macrophages and TLR4 and TLR2 in BGN-associated inflammatory processes.
Discussion
In the present studies, we have identified a new role of BGN as a crucial proinflammatory factor. The most convincing evidence for the biological relevance of this finding is the observation that Bgn-null mice have a considerable survival benefit compared with WT animals, both in LPS-induced and in zymosan-induced sepsis, due to a mitigated inflammatory response that results in less end-organ damage. This survival benefit in Bgn-null mice is probably due to the fact that the initial sequence of inflammatory ESI/MS/MS of bands labeled in F as 1 (G and H) and 2 (I and J) recognized human BGN with a probability-based score of 221 (G) and with a sequence coverage of 13% (H) and mouse TLR4 with a probability-based score of 528 (I) and with a sequence coverage of 8% (J). MOWSE, molecular weight search.
events, namely PAMP-triggered expression of proinflammatory factors such as IL-1β and IL-6, subsequent IL-1β/IL-6-induced expression of BGN in macrophages, and finally BGN-induced expression of TNF-α, is interrupted in the absence of BGN. The relevance of this interpretation of our data is underscored by the observation that the increased secretion of IL-1β and IL-6 as an initial response to LPS is indistinguishable in Bgn-deficient and WT macrophages, while the subsequent TNF-α production is significantly reduced in the Bgn-deficient macrophages because of the lack of costimulatory effects of BGN. Regulation of TNF-α by BGN has not been reported previously, although in lung fibroblasts TNF-α has been proven to induce the expression of BGN (40) . Since the initial release of TNF-α is of critical importance for the outcome of sepsis, therapeutic strategies to neutralize this cytokine have been developed, but no clear-cut survival benefits have been achieved so far (41) . This study demonstrates that in the early stages of sepsis, serum levels of TNF-α are considerably lower in Bgn-deficient than in WT mice.
The importance of BGN during sepsis is underlined by the fact that BGN overexpression could be observed in septic lungs, at both mRNA and protein levels. Early upregulation of BGN in pulmonary inflammation has already been reported (42, 43) ; however, its biological relevance remained unclear. We previously observed a striking concurrence of BGN overexpression and enhanced numbers of infiltrating cells in a model of renal inflammation (14) . In the present study we confirmed this relationship in the lung and addressed the potential mechanism in vitro by showing that BGN, besides TNF-α, induces the expression of MIP-2, a potent chemoattractant of infiltrating cells (44) . Enhanced numbers of macrophages were in fact triggered by BGN, since other ECM components, such as fibronectin, laminin, and types I and VI collagen, which could potentially increase monocyte sticking (34, 35) , were upregulated to the same extent in lungs from septic Bgn +/0 and Bgn -/0 mice. BGN regulates lung fibroblast migration via stimulation of the small GTPases RhoA and Rac1 (6) . Interestingly, both the Rho proteins and the p38 MAPK pathways have been shown to be important mediators of LPS-induced expression of IL-8, a human MIP-2 homolog, in human endothelial cells (45) .
It is particularly noteworthy that macrophages, seminal cells of the innate immune system (24) , are capable of producing BGN upon stimulation by proinflammatory factors. Previously, we have shown that macrophages do contain and secrete BGN in a model of renal inflammation (14) . A recent study reported BGN in association with macrophages in human gingiva (46) . In the present investigation, we found that unstimulated peritoneal macrophages do not express BGN. However, once activated by IL-6 and IL-1β, macrophages start to express BGN mRNA and secrete the proteoglycan into the culture medium. Although the presence of an IL-6-responsive element in the BGN promoter region has been reported (36), the IL-1β-and IL-6-triggered expression of BGN in macrophages is, to our knowledge, a novel finding. The fact that macrophages produce BGN only upon inflammatory stimulation underlines the biological importance of this proteoglycan in terms of its influence on inflammation. As only soluble BGN is active in stimulating macrophages, presumably because in the immobilized state the binding sites for macrophage receptors are inaccessible because of binding of BGN to other ECM components, we suggest that regulation is achieved via the amount of BGN liberated from immobilized pools by the activity of proteolytic enzymes in the course of sepsis, rather than via fine-tuning of BGN expression levels. Thus, only Bgn-null mice could be seen to have a survival benefit in sepsis, which suggests that, in heterozygous females, sufficiently high tissue content of BGN is present to support macrophage activation.
Our data showing that BGN interacts with TLR4 and to a lesser extent with TLR2, and the subsequent predominantly MyD88-dependent induction of ERK, p38, and NF-κB, significantly extend the knowledge of the biology of BGN for 2 reasons: (a) the data confirm that BGN acts as a signaling molecule, and (b) they firmly establish this proteoglycan as an integral part of the innate immune system. Although the involvement of BGN in various signaling processes has been addressed (4-6, 15, 33) , this is, to our knowledge, the first report to provide evidence for BGN-mediated signal transduction in macrophages, starting from the initial receptors and describing the downstream signaling events and the inflammatory mediators subsequently generated. Various structural molecules have been reported to modulate an inflammatory response reaction (9) (10) (11) (12) (13) 47) . Glycosaminoglycan (GAG) chains are well known to act as targets for bacterial, viral, and parasitic virulence factors for attachment, invasion, and immune evasion (48) (49) (50) . In our study, only intact BGN and to a lesser extent the intact decorin molecule were able to deliver a proinflammatory signal to macrophages. Thus, BGN-mediated stimulation of macrophages is not due to a general effect of GAG chains but was shown to be in fact BGN-specific. Recent studies demonstrated that ECM components, previously only regarded as docking sites for microbial pathogens, might actively participate in immune defense as an integral part of the innate immune system (9, (11) (12) (13) . Among these ECM molecules, fibronectin extra domain A (11) and hyaluronan-derived oligosaccharides (9) have been shown to activate TLR4. Our study provides evidence that the ECM component BGN is also actively involved in the innate immune response. In contrast to hyaluronan (9, 13), BGN strongly influences the effector phase of an immune reaction (e.g., increase in activity of macrophages). BGN effectively uses the TLR signaling cascade by binding to both TLR4 and TLR2. Contaminations are unlikely to have caused the effects. Apart from the neutralizing activity of antibodies directed against BGN, which strongly implicates BGN as the active component, contaminatory products have been excluded by several assays as outlined in the supplemental material. Most importantly, our data show a clear survival benefit of Bgn-null mice in TLR4- and TLR2-dependent models of sepsis but not in SEB-mediated shock, where T lymphocytes and not macrophages are triggered in a TLR-independent way (39) . Further evidence for BGN-specific TLR4- and TLR2-mediated proinflammatory effects is provided by the observation that BGN and LPS signal differently in TLR4-M and MyD88 -/-macrophages. The fact that BGN-induced signaling in macrophages is mediated by 2 receptors important in the recognition of both Gram-negative (26) (27) (28) 37) and Gram-positive pathogens (24) emphasizes the key role of this proteoglycan within the innate immune system. In summary, our results demonstrate the biological relevance of BGN in a prototypical innate immune process such as sepsis and identify a novel role of BGN as a crucial proinflammatory factor. Being ubiquitously present in the ECM, BGN can be liberated during inflammation by proteolytic enzymes, or alternatively be induced in macrophages by PAMP-triggered cytokines, to signal through the classical PAMP receptors TLR4 and TLR2. Subsequent expression of TNF-α and MIP-2 will cause recruitment of more macrophages, which also will start to produce BGN, creating a feed-forward cycle that is able to drive an inflammatory response forward in both an autocrine and a paracrine manner.
Methods
Mice. Female Bgn -/-and Bgn -/+ and male Bgn -/0 , Bgn +/+ , and Bgn +/0 mice (C57BL/6) have been previously described (3) . Since the Bgn gene is located on the X chromosome, male animals have only 1 allele. TLR4-M mice with a TLR4 gene point mutation (C3H/HeJ) (26, 37) Cell culture and stimulation. Macrophages were harvested by peritoneal lavage 5 days after injection of thioglycollate, and cultured in RPMI 1640 (Invitrogen Corp.) under serum-free conditions. Only adherent cells were used for primary cultures. Purity was controlled by flow cytometry and Giemsa staining. LPS, cell culture-tested, from S. minnesota and peptidoglycan from Staphylococcus aureus were both from Sigma-Aldrich. Ultrapure LPS from S. minnesota was from InvivoGen. To control responsiveness, cells from each isolation were stimulated with LPS (0.1 ng/ml) and/or peptidoglycan (5 µg/ml) for 2 hours and tested for secreted TNF-α. Intact BGN, BGN core protein, or BGN-derived GAG chains were used in concentrations of 1-10 µg/ml. If it is not indicated otherwise, experiments were done with 4 µg/ml of BGN. When required, macrophages were preincubated for 30 minutes with rat anti-mouse TLR4 blocking antibodies (40 µg/ml; Imgenex) recognizing the TLR4/MD-2 complex, or for 1 hour with 10 µM of MEK1/2 inhibitor (U0126; Cell Signaling Technology) or p38 MAPK inhibitor (SB203580; Sigma-Aldrich). Stimulation of macrophages was performed with recombinant mouse IL-1β (10 ng/ml; Sigma-Aldrich) or human IL-6 (10 ng/ml; R&D Systems).
HEK293 cells stably transfected with pNIFTY2-SEAP vectors containing human TLR4, MD-2, and CD14 genes (HEK-Blue-4) or human TLR2 and CD14 genes (TLR2/CD14) and 293/null (control) cells (all from InvivoGen) were cultured according to the manufacturer's instructions.
Northern blot analysis, RT-PCR, and in situ hybridization. Total RNA was extracted using TRIzol (Invitrogen Corp.). Membranes were hybridized with 32 P-labeled cDNA probes for BGN (51), TNF-α (American Type Culture Collection), and MIP-2 (52). A mouse α-tubulin probe encompassing bp 365-965 (GenBank accession number M13446), generated by RT-PCR (53) with the primer pair 5′-AAGGAGGATGCTGCCAATAA-3′ and 5′-AGAGATCACCAATGCCTGCT-3′, was used to control for equal loading. Northern blots were performed and quantified as described previously (53) . RT-PCR for BGN and GAPDH and in situ hybridization for BGN were described previously (51) .
Western blotting and ELISA. Western and dot blots were performed and quantified as described previously (53) . The following antibodies were used: rabbit anti-human TLR4 cross-reacting with mouse TLR4, and rabbit anti-β-tubulin (both from Santa Cruz Biotechnology Inc.); rabbit antimouse TLR2 and rabbit anti-human TLR2 (both from Imgenex Corp.); rabbit anti-mouse pan-laminin and rabbit anti-human fibronectin (both from Sigma-Aldrich); and rabbit antibodies against phosphorylated and total ERK (Thr202/204) and p38 (Thr180/Tyr182) MAPK (all from Cell Signaling Technology). BGN core protein from murine lungs was semipurified and quantified by dot blotting using LF-106, a rabbit anti-murine BGN antiserum kindly provided by L.W. Fisher (National Institute of Dental and Craniofacial Research) (54), as described previously (53) . Dot blot results were confirmed by Western blotting and standardized to the content of β-tubulin in the samples before purification. TNF-α, MIP-2, IL-6, and IL-1β were measured in plasma, culture media, and homogenates of macrophages by mouse-specific ELISAs (R&D Systems). Results were normalized by protein content and cell number. All assays were performed in duplicate, and each experiment was carried out at least 3 times.
Activation of TLRs by BGN. BGN-induced stimulation via TLR2, -3, -4, -5,
-7, -8, or -9 was tested in HEK293 cells expressing only 1 type of TLR and secreted alkaline phosphatase under the control of a modified human IL-12p40 promoter inducible by NF-κB, activator protein-1, and IFN-regulatory factors cloned into pNIFTY2-SEAP vectors. The amount of secreted alkaline phosphatase was determined using the SEAP Reporter Assay Kit (measurements were performed by TLR screening service of InvivoGen) and is given as arbitrary units. Screening was performed (in duplicate) by challenge of the 7 TLR clones with 10 µg/ml of BGN and comparison of the induced alkaline phosphatase activity to that of negative controls (respective noninduced TLR clones) and that of positive controls stimulated with the following ligands: FSL-1 (10 ng/ml) for TLR2, poly I:C (10 µg/ml) for TLR3, LPS-K12 (10 and 1 ng/ml) for TLR4, flagellin (100 ng/ml) for TLR5, R848 (1 µg/ml) for TLR7 and -8, and ODN 2006 (10 µg/ml) for TLR9 (InvivoGen). Dose-response analysis was performed (in triplicate) using BGN (10 µg/ml, 1 µg/ml, 0.1 µg/ml) on the respective TLR cell lines.
Immunoprecipitation and protein identification by ESI/MS/MS. Immunoprecipitation of human BGN was performed as described previously (55) with some modifications. Thioglycollate-elicited Bgn -/0 , TLR2 -/-, or TLR4 -/-macrophages (10 7 cells) or HEK-Blue-4, TLR2/CD14, and 293/ null cells were incubated with 8 µg of intact human BGN for 2 hours at 4°C and then with 1 mM 3,3′-dithiobis(sulfo-succinimidyl propionate) (DTSSP; Pierce Biotechnology Inc.) for cross-linking of BGN to binding proteins. Cells were harvested in radioimmunoprecipitation (RIPA) buffer, and a complex of normal rabbit serum bound to protein A-Sepharose (Sigma-Aldrich) was added for 6 hours to remove nonspecifically precipitated proteins. Then 10 µg of rabbit anti-human BGN (55) was added, and after 16 hours the immune complexes were precipitated with protein A-Sepharose. As control, a similar amount of protein A-Sepharose was incubated with the antibody but without cell lysate. Additional controls included samples incubated without cross-linker and/or without BGN. After washing (3 times in lysis buffer, twice in PBS), the material containing intact BGN was divided into 2 aliquots. One aliquot was treated with chondroitinase ABC. Bound proteins were eluted by boiling in the respective sample buffer (55) . Some immunoprecipitations for BGN were performed using rabbit IgG TrueBlot (eBioscience) according to the manufacturer's suggestion. Samples were examined by Western blotting for the presence of TLR4 and BGN, using BGN core protein and homogenates of TLR2 -/-and TLR4 -/-macrophages, HEK-Blue-4, TLR2/ CD14, and 293/null cells as positive or negative controls. After separation by 1D SDS gel electrophoresis, identification of human BGN and mouse TLR4 by proteomics service (MS-ESI-PROTID; Eurogentec) using ESI/MS/MS was performed in Bgn -/0 macrophages incubated with BGN, immunoprecipitated for BGN, and digested with chondroitinase ABC. Results were analyzed by a Mascot database search (Matrix Science Ltd.).
Morphology and immunohistochemistry. Formaldehyde- or zinc-fixed and paraffin-embedded lung tissue sections were stained for matrix antigens and mononuclear cells by immunoperoxidase, alkaline phosphatase, anti-alkaline phosphatase, or streptavidin/biotin-alkaline phosphatase techniques (51, 52) . Primary antibodies included LF-113, a rabbit anti-murine decorin antiserum (54), LF-106 (1:500), rabbit anti-mouse fibromodulin (1:100) (33), rabbit anti-rat type I collagen (1:50; Quartett GmbH), rabbit anti-human fibronectin (1:200; Sigma-Aldrich), biotinylated goat anti-type VI collagen (1:20; Southern Biotechnology Associates Inc.), and, for populations of monocytes/ macrophages, rat anti-mouse F4/80 (1:2,000; BD Biosciences - Pharmingen). Double-immunostaining for BGN (chicken anti-rat BGN) (51) and F4/80 was performed as described previously (56) . Immunolabeled and H&E-stained mononuclear cells were counted by a blinded observer in 15 high-power fields (×400) per section and recorded as mean per high-power field.
Other procedures. Expression of human BGN and decorin in HEK293 cells and purification of the native proteoglycans were described previously
